Patient Medication Information
Through a cooperative agreement, the Engelberg Center for Health Care Reform worked in collaboration with FDA to convene four workshops between May 2010 and July 2014 to discuss optimizing, implementing, and evaluating adoption of a single standard medication information document.
Two of the meetings were expert workshops involving a small group of subject matter experts charged with the task of exploring focused topics, while two meetings were large public workshops to solicit perspectives from all relevant stakeholders (federal agencies, pharmacies, health care plans, pharmacy benefit managers, manufacturers, CMI publishers, providers, hospitals, patients, and consumers).
For each workshop, ECHCR worked with FDA to identify key discussion topics and expert speakers. Other responsibilities of the Center included planning and hosting the events, preparing pre-meeting issue briefs that describe key challenges and questions for discussion to guide the meeting, and creating meeting summaries after each workshop.
Each of these four workshops focused on a different aspect of PMI:
Exploring the Promise of Patient Medication Information
July 1, 2014
The fourth meeting was a large public workshop that discussed findings from a variety of PMI projects undertaken by researchers and other stakeholders in the health care community, in addition to progress made on the PMI initiative over the past several years. Meeting participants explored lessons learned from those engaged in these PMI projects and the role of stakeholders who regularly interface with PMI in moving the PMI initiative forward.
Designing Pilot Programs to Distribute Patient Medication Information
February 23, 2011
The third meeting was a small expert workshop to discuss the development of innovative yet practical pilots to evaluate distribution of PMI to patients. Several independent groups presented outlines for potential distribution pilots and experts commented on pilot design, implementation of pilots, and proposed strategies to evaluate distribution through pilots.
Ensuring Access to Effective Patient Medication Information (PMI)
October 12, 2010
The second meeting was a large public workshop. The primary objective of this workshop was to discuss strategies to ensure that patients have access to effective PMI. A series of panel discussions explored patient expectations for PMI and how they access it, along with feasible solutions for delivering high quality PMI to patients.
The Science of Communicating Medication Information to Consumers
July 21, 2010
The first meeting was a small expert workshop that focused on the optimal content and format of a single-page standard patient medication information document as well as metrics to evaluate CMI effectiveness. Experts discussed FDA’s three draft prototypes (which were informed by ideas presented during a public workshop in September 2009) and FDA’s proposed strategy for evaluating the prototypes in a consumer testing study.